(Q35081121)

6 August 2017

1 reference

title

Identification of tumor-associated antigens using proteomics (English)

1 reference

6 August 2017

François L Naour

1

1 reference

6 August 2017

Franck Brichory

series ordinal

2

1 reference

6 August 2017

Laura Beretta

series ordinal

3

1 reference

6 August 2017

Samir M Hanash

series ordinal

4

1 reference

6 August 2017

1 August 2002

1 reference

Technology in Cancer Research and Treatment

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

4

1 reference

6 August 2017

257-262

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

6 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Vaccination for malignant melanoma: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

A proteomic approach to the identification of lung cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Proteomic-based approach for the identification of tumor markers associated with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Ubiquitin-dependent protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

PGP9.5 as a candidate tumor marker for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Serum levels of interleukin 6 in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100406

10.1177/153303460200100406

21 January 2018

Identifiers

DOI

0 references

1 reference